Ausgewählte Publikationen

Gölder S, Vogt W, Lichti H, Rath HC, Kullmann A, Schölmerich J, Kullmann F. Acceptance of flexible sigmoidoscopy as a screening examination for colorectal cancer in an outpatient clinic. Int J Colorectal Dis. 2006 Jul 4

McBurney W, Mangold M, Munro K, Schultz M, Rath HC, Tannock GW. PCR/DGGE and 16S rRNA gene library analysis of the colonic microbiota of HLA-B27/beta2-microglobulin transgenic rats.Lett Appl Microbiol. 2006 Feb;42(2):165-71.

Ratiu N, Rath HC, Buttner R, Gelbmann C, Klebl F, Kullmann F, Rogler G, Strauch UG, Schölmerich J, Messmann H. The effect of chromoendoscopy on the diagnostic improvement of gastric ulcers by endoscopists with different levels of experience. Rom J Gastroenterol. 2005 Sep;14(3):239-44.

Strauch UG, Obermeier F, Grunwald N, Gurster S, Dunger N, Schultz M, Griese DP, Mahler M, Schölmerich J, Rath HC. Influence of intestinal bacteria on induction of regulatory T cells: lessons from a transfer model of colitis. Gut. 2005 Nov;54(11):1546-52. Epub 2005 Jun 29.

Obermeier F, Strauch UG, Dunger N, Grunwald N, Rath HC, Herfarth H, Schölmerich J, Falk W. In vivo CpG DNA/toll-like receptor 9 interaction induces regulatory properties in CD4+CD62L+ T cells which prevent intestinal inflammation in the SCID transfer model of colitis. Gut. 2005 Oct;54(10):1428-36. Epub 2005 May 5.

Schultz M, Watzl S, Oelschlaeger TA, Rath HC, Gottl C, Lehn N, Schölmerich J, Linde HJ. Green fluorescent protein for detection of the probiotic microorganism Escherichia coli strain Nissle 1917 (EcN) in vivo. J Microbiol Methods. 2005 Jun;61(3):389-98.

Schreyer AG, Rath HC, Kikinis R, Volk M, Schölmerich J, Feuerbach S, Rogler G, Seitz J, Herfarth H. Comparison of magnetic resonance imaging colonography with conventional colonoscopy for the assessment of intestinal inflammation in patients with inflammatory bowel disease: a feasibility study. Gut. 2005 Feb;54(2):250-6.

Gelbmann CM, Ratiu NL, Rath HC, Rogler G, Lock G, Schölmerich J, Kullmann F. Use of self-expandable plastic stents for the treatment of esophageal perforations and symptomatic anastomotic leaks. Endoscopy. 2004 Aug;36(8):695-9.

Rath HC, Timmer A, Kunkel C, Endlicher E, Grossmann J, Hellerbrand C, Herfarth HH, Lock G, Sahrbacher U, Schölmerich J, Kullmann F, Messmann H. Comparison of interobserver agreement for different scoring systems for reflux esophagitis: Impact of level of experience. Gastrointest Endosc. 2004 Jul;60(1):44-9.

Schultz M, Munro K, Tannock GW, Melchner I, Gottl C, Schwietz H, Schölmerich J, Rath HC. Effects of feeding a probiotic preparation (SIM) containing inulin on the severity of colitis and on the composition of the intestinal microflora in HLA-B27 transgenic rats. Clin Diagn Lab Immunol. 2004 May;11(3):581-7.

Schultz M, Timmer A, Herfarth HH, Sartor RB, Vanderhoof JA, Rath HC. Lactobacillus GG in inducing and maintaining remission of Crohn's disease. BMC Gastroenterol. 2004 Mar 15;4:5.

Schultz M, Strauch UG, Linde HJ, Watzl S, Obermeier F, Gottl C, Dunger N, Grunwald N, Schölmerich J, Rath HC. Preventive effects of Escherichia coli strain Nissle 1917 on acute and chronic intestinal inflammation in two different murine models of colitis. Clin Diagn Lab Immunol. 2004 Mar;11(2):372-8.

Rath HC, Schultz M, Freitag R, Dieleman LA, Li F, Linde HJ, Schölmerich J, Sartor RB. Different subsets of enteric bacteria induce and perpetuate experimental colitis in rats and mice. Infect Immun. 2001 Apr;69(4):2277-85.

Rath HC, Wilson KH, Sartor RB. Differential induction of colitis and gastritis in HLA-B27 transgenic rats selectively colonized with Bacteroides vulgatus or Escherichia coli. Infect Immun. 1999 Jun;67(6):2969-74.

Rath HC, Ikeda JS, Linde HJ, Schölmerich J, Wilson KH, Sartor RB. Varying cecal bacterial loads influences colitis and gastritis in HLA-B27 transgenic rats. Gastroenterology. 1999 Feb;116(2):310-9.

Herfarth HH, Mohanty SP, Rath HC, Tonkonogy S, Sartor RB. Interleukin 10 suppresses experimental chronic, granulomatous inflammation induced by bacterial cell wall polymers. Gut. 1996 Dec;39(96):836-45.

Rath HC, Herfarth HH, Ikeda JS, Grenther WB, Hamm TE Jr, Balish E, Taurog JD, Hammer RE, Wilson KH, Sartor RB. Normal luminal bacteria, especially Bacteroides species, mediate chronic colitis, gastritis, and arthritis in HLA-B27/human beta2 microglobulin transgenic rats. J Clin Invest. 1996 Aug 15;98(4):945-53.

Übersichten:

Lock G, Holstege A, Rath HC, Schölmerich J. Hepatic manifestations in Crohn’s disease and ulcerative colitis. Z.Arztl.Fortbild.(Jena) 1994;88: 373-380.

Sartor RB, Rath HC, Sellon RK. Microbial factors in chronic intestinal inflammation. Curr.Opin.Gastroenterol. 1996;12: 327-333.

Sartor RB, Rath HC, Lichtman SN, van Tol EAF. Animal models of intestinal and joint inflammation. Bailliere.Clin.Rheumatol. 1996;10: 55-76.

Herfarth HH, Rath HC, Schölmerich J. Crohn’s disease – New insights into the pathogenesis and therapy. Gazette Médicale 1998;19: 919-924.

Rath HC. Ist die abnormale Immunantwort gegenüber normalen Darmbakterien die Ursache für chronisch entzündliche Darmerkrankungen? Bauchredner 1999;56: 38-45.

Rath HC. The Potential Role of Infectious Agents in the Etiology of Inflammatory Bowel Diseases. Sem.Col.Rect.Surg. 2001;12(1):9-15

Rath HC. Bakterien als Ursache der Colitis ulcerosa? Bauchredner, 2001; 64(1): 83-85

Rath HC. Der Einfluss der bakteriellen Darmflora auf chronisch entzündliche Darmerkrankungen – Lehren aus dem Tiermodell. Dtsch Tierärztl Wschr, 2001; 108(4):180-181.

Rath HC, Herfarth HH. Behandlung extraintestinaler Manifestationen bei chronisch entzündlichen Darmerkrankungen. Versicherungsmedizin 2002; 54(1):16-20.

Rath HC. Role of Commensal Bacteria in Chronic Experimental Colitis: Lessons from the HLA-B27 Transgenic Rat. Pathobiology. 2003;70(3):131-8.

Wiest R, Rath HC. Bacterial translocation in the gut. Best Pract Res Clin Gastroenterol 2003 Jun;17(3):397-425.

Rath HC. The role of endogenous bacterial flora: bystander or necessary prerequisite? Eur J Gastroenterol Hepatol 2003;15(6):615-620

Rath HC. Welche Rolle spielen Prä- und Probiotika in der Behandlung der CED. Bauchredner, 2003;73(2): 48-54.

Schultz M, Scholmerich J, Rath HC. Rationale for probiotic and antibiotic treatment strategies in inflammatory bowel diseases. Dig Dis. 2003;21(2):105-28.

Buchbeiträge:

Gross V, Andus T, Caesar I, Rath HC, Schölmerich J. Inflammatory Bowel Disease - Laboratory Assessment. In: Stange EF, ed. Chronic inflammatory bowel disease. Lancaster: Kluwer Academic Publishers, 1995: 73-87.

Rath HC. Spontaneous colitis and gastritis in HLA-B27/beta2-microglobilun transgenic rats and its association with normal luminal bacteria. In: Emmrich J, Liebe S, Stange EF, eds. Innovative concepts in inflammatory bowel disease. Dordrecht, Boston, London: Kluwer Academic Publishers, 1999: 52-60.

Schultz M, Rath HC. The possible role of probiotic therapy in inflammatory bowel disease. In: Tannock GW (ed). Probiotics and prebiotics: were are we going? Horizon Scientific Press, Norfolk, UK. 2002: 175-238

Andus T, Herfarth H, Rath HC. Therapie von Erkrankungen des Dünn- und Dickdarms. In: Schömerich J, Sewing K-F (eds). Arzneimitteltherapie in der Gastroenterologie. Wissenschaftliche Verlagsgesellschaft, Stuttgart, 2003: 111-132

Rath HC. Microbial factors. In: Satsangi J, Sutherland L (eds). Inflammatory bowel disease. 4th edition. Churchill Livingstone, Elsevier, Philadelphia. 2003: 45-62.